RESUMEN
We assessed the prognostic value of the platelet to lymphocyte ratio (PLR) in primary percutaneous coronary intervention (pPCI). Patients (n = 440) with acute myocardial infarction (AMI) who underwent pPCI were divided into 2 groups: low PLR (<137) and high PLR (>137). "Thrombolysis In Myocardial Infarction" (TIMI) flow grades and Syntax scores (SXS) were calculated from initial angiograms. In-hospital mortality rate and cardiac adverse events were obtained from medical records. Patients with high PLR had more no-reflow, higher SXS and higher mortality rate (p < 0.001, p < 0.001 and p = 0.008, respectively). In receiver operating characteristic curve analysis, high PLR predicted development of no-reflow (specificity 71% and sensitivity 85%), SXS>22 (specificity 52% and sensitivity 61%) and adverse events (specificity 67% and sensitivity 63%). In multivariate regression analysis, PLR was an independent risk factor for no-reflow, SXS>22 and in-hospital adverse events. In addition to PLR, we present the relationship between mean platelet volume, red cell distribution width and neutrophil to lymphocyte ratio and no-reflow, SXS and in-hospital adverse events.
Asunto(s)
Recuento de Linfocitos , Intervención Coronaria Percutánea/efectos adversos , Recuento de Plaquetas , Adulto , Anciano , Anciano de 80 o más Años , Biomarcadores , Femenino , Hospitalización , Humanos , Masculino , Persona de Mediana Edad , Infarto del Miocardio/sangre , Infarto del Miocardio/diagnóstico , Infarto del Miocardio/etiología , Infarto del Miocardio/cirugía , Pronóstico , Curva ROC , Estudios RetrospectivosRESUMEN
BACKGROUND: Heart rate turbulence (HRT) is a baroreflex-mediated biphasic reaction of heart rate in response to premature ventricular beats. Abnormal HRT identifies patients with autonomic dysfunction or impaired baroreflex sensitivity. The aim of the present study was to demonstrate the effect of subclinical hypothyroidism (SCH) on cardiac autonomic function using HRT parameters. METHODS: The study sample consisted of 25 patients (10 men, 15 women with a mean age of 39.7 ± 15.5 years) who were diagnosed with SCH and 35 euthyroid patients (13 males, 22 females with a mean age 38.4 ± 11.7 years). All patients underwent 24 h ambulatory electrocardiography monitorization. The study calculated two HRT parameters, turbulence slope (TS) and turbulence onset (TO), and these HRT parameters were compared between the groups to examine the relationship between HRT and thyroid-stimulating hormone (TSH) levels. RESULTS: The characteristics of SCH patients and control cases were similar with regard to age, sex except for TSH levels. Serum TSH levels were significantly higher in SCH patients than in the controls (7.3 ± 1.8 µIU/ml vs. 2.4 ± 1.0 µIU/ml, p < 0.001). TO was significantly higher in SCH patients compared with controls (-1.51 ± 0.5 vs. -2.2 ± 1.0, p = 0.002). SCH patients had lower TS values than controls (7.6 ± 2.4 vs. 10.8 ± 3.4, p < 0.001). TO was positively correlated with serum TSH levels (r = 0.276, p = 0.033). There was also a negative correlation between TS and serum TSH levels (r = -0.437, p < 0.001). CONCLUSIONS: The results of our study indicated that cardiac autonomic function is impaired in patients with SCH. KEY WORDS: Heart rate; Holter electrocardiography; Hypothyroidism.
RESUMEN
BACKGROUND: It has been shown that increased red blood cell distribution width (RDW) predicts adverse outcomes in cardiovascular disease and in patients undergoing a percutaneous coronary intervention. The aim of the present study was to assess the predictive value of preinterventional RDW on the development of in-stent restenosis (ISR) in patients undergoing stent implantation. MATERIALS AND METHODS: In this retrospective study, we compared 131 patients with ISR and 138 patients without ISR who had undergone bare metal stent implantation. RESULTS: Preprocedural RDW was significantly higher in patients with ISR than those without restenosis (14.6±3.2 vs. 13.4±1.6%, P<0.001). Stent length was significantly longer in patients with than those without restenosis (17.9±5.6 vs. 16.2±5.2 mm, respectively, P=0.03). Compared with patients with restenosis, patients without restenosis had a lower rate of diabetes (28 vs. 61 patients, P=0.001), a significantly short period between two coronary angiographies (9.8±9.3 vs. 12.9±11.6 months, respectively, P=0.02), and lower triglyceride levels (133±53 vs. 198±121 mg/dl, respectively, P=0.05). In multivariate logistic regression analysis, diabetes mellitus, stent length, preprocedural RDW, and current smoking independently predicted ISR. CONCLUSION: Increased preinterventional RDW significantly predicts bare metal stent restenosis and might represent a useful screening tool to stratify patients according to a higher or a lower risk of ISR after stent implantation in patients with stable and unstable angina pectoris.
Asunto(s)
Angina Estable/terapia , Angina Inestable/terapia , Reestenosis Coronaria/etiología , Índices de Eritrocitos , Metales , Intervención Coronaria Percutánea/efectos adversos , Intervención Coronaria Percutánea/instrumentación , Stents , Anciano , Angina Estable/sangre , Angina Estable/diagnóstico , Angina Inestable/sangre , Angina Inestable/diagnóstico , Distribución de Chi-Cuadrado , Reestenosis Coronaria/sangre , Reestenosis Coronaria/diagnóstico , Femenino , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Oportunidad Relativa , Valor Predictivo de las Pruebas , Diseño de Prótesis , Estudios Retrospectivos , Medición de Riesgo , Factores de Riesgo , Factores de Tiempo , Resultado del TratamientoRESUMEN
OBJECTIVE: It is suggested that the apolipoprotein (Apo) B levels are more valuable than LDL cholesterol (LDL-C) levels in assessing cardiovascular risk associated with hyperlipidaemia. However, although non-HDL cholesterol (non-HDL-C) levels are accepted as a secondary objective after achieving LDL-C levels in the guidelines, Apo B has not been recommended as a therapeutic goal yet. The objective of this study was to determine how many of the patients who achieved the LDL-C and non-HDL-C target recommended by the guidelines with a statin therapy achieved the Apo B target. METHODS: The study included a total of 182 consecutive hypercholesterolaemic (119 male, 63 female) patients who were over 18 years of age (mean age: 54.96 +/- 9.27 y) and on statin therapy. Apo B and non-HDL-C levels were determined for the patients who achieved or did not achieve the LDL-C target according to the cardiovascular risk categories defined in the Adult Treatment Panel-III report. Serum Apo B levels were assessed using the nephelometric method. RESULTS: The prevalence of patients who achieved the LDL-C, non-HDL-C and Apo B target was 63.2%, 79.7% and 72.5%, respectively. All of the patients who achieved the LDL-C target also achieved the non-HDL-C target. It was found that 6 of 115 patients (5.2%) who achieved the LDL-C and non-HDL-C target failed to achieve the Apo B target, whereas 23 of 132 patients (17.4%) who achieved the Apo B target failed to achieve the LDL-C target. CONCLUSIONS: These results showed that 95% of patients who received a statin therapy, and achieved LDL-C and non-HDL-C targets also achieved the Apo B target.
Asunto(s)
Apolipoproteínas B/sangre , HDL-Colesterol/sangre , LDL-Colesterol/sangre , Hiperlipidemias/sangre , Femenino , Humanos , Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico , Hipercolesterolemia/sangre , Hipercolesterolemia/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Medición de RiesgoRESUMEN
Coronary artery bypass grafting is one of the routine daily surgical procedures in the current era. Parallel to the increasing life expectancy, cardiac surgery is commonly performed in octogenarians. However, literature consists of only seldom reports of coronary artery bypass grafting in patients above 90 years of age. In this report, we present our management strategy in a 105-year-old patient who underwent coronary artery bypass grafting at our institution.
RESUMEN
OBJECTIVE: The heart rate variability (HRV) has been used in patients with heart failure as a non-invasive method and provided neuro-cardiovascular evaluation. This study was planned to determine the efficacy and prognostic value of 24-hour and short time HRV in autonomic dysfunction in patients with congestive heart failure. METHODS: Forty-six patients with symptomatic or asymptomatic left ventricular dysfunction (ejection fraction <40%) were included to the study. In the study group, 16 patients were in NYHA class I (35%), 19 - were in NYHA class II (41%) and 11 - were in NYHA class III (24%). In the first day, HRV was evaluated from the 24-hour Holter recordings. Following day; we assessed the HRV during: (1) 10 min of supine resting, (2) 10 min of regular breathing at a frequency of 20 acts/min, and (3) 10 min of passive orthostatism after tilting 80 degrees with tilt table. RESULTS: Twenty-four hour and short time recordings of HRV showed significant decrease in long-term LF/HF24 (LF- low frequency, HF- high frequency), and short-term LF/HFsupine, LF/HFbreathing and LF/HFtilt ratios in patients with NYHA class III when compared with the patients in NYHA class I-II (p=0.0001, p=0.01, p=0.03, p=0.0001, respectively). During 446+/-186 days of follow-up, cardiovascular end-points occurred in 20 patients. In Cox multivariate analysis, significant predictors of cardiac mortality and morbidity were, reduced LF/HF ratio (HR=0.4, 95% CI 0.31-0.73, p=0.001) in the 24-hour recordings and low left ventricular ejection fraction (HR=0.9, 95% CI 0.83-0.99, p=0.03). CONCLUSION: Our study demonstrated that both of the methods were useful for assessment of cardiac autonomic dysfunction and only 24-hour recordings of HRV had a prognostic value.